Aditxt (ADTX) Non Operating Income (2019 - 2026)
Aditxt (ADTX) recorded quarterly Non Operating Income of -$11.8 million in Q1 2026, down 2005.76% quarter-over-quarter from -$561667.0 in Q4 2025, and down 3334.68% on a YoY basis from $365641.1 in Q1 2025.
Aditxt (ADTX) Non Operating Income (2019 - 2026) Analysis & Trends
Aditxt's Non Operating Income history runs 8 years deep, the most recent figure standing at -$11.8 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 3334.68% year-over-year to -$11.8 million; the TTM figure through Mar 2026 stood at -$34.7 million (down 732.58% YoY), while the FY2025 annual figure was -$23.2 million, down 224.42% from the prior year.
- Non Operating Income was -$11.8 million for Q1 2026 at Aditxt, down from -$561667.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $103861.0 in Q4 2024 to a low of -$21.1 million in Q3 2025.
- Historically, Non Operating Income has averaged -$3.0 million across 5 years, with a median of -$1.4 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income soared 120.16% in 2022, then sank 18032.09% in 2023.
- A 5-year view of Non Operating Income shows it stood at $16880.0 in 2022, then tumbled by 18032.09% to -$3.0 million in 2023, then surged by 103.43% to $103861.0 in 2024, then tumbled by 640.79% to -$561667.0 in 2025, then tumbled by 2005.76% to -$11.8 million in 2026.
- The last three Non Operating Income figures came in at -$11.8 million (Q1 2026), -$561667.0 (Q4 2025), and -$21.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -11.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.83 Mn |
| Dec 31, 2025 | -561,667.00 |
| Sep 30, 2025 | -21.07 Mn |
| Jun 30, 2025 | -1.24 Mn |
| Mar 31, 2025 | -344,350.00 |
| Dec 31, 2024 | 103,861.00 |
| Sep 30, 2024 | -2.28 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | -3.33 Mn |
| Dec 31, 2023 | -3.03 Mn |
| Sep 30, 2023 | -1.65 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -202,811.00 |
| Dec 31, 2022 | 16,880.00 |
| Sep 30, 2022 | -2.17 Mn |
| Jun 30, 2022 | -79,049.00 |
| Mar 31, 2022 | 57,790.00 |
| Dec 31, 2021 | 8.81 Mn |
| Sep 30, 2021 | -3.69 Mn |
| Jun 30, 2021 | -403,429.00 |